Inhibition by various antiarthritic agents of murine splenic B cell colony formation

Yoshiyuki Ohsugi, M. Eric Gershwin

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

There is accumulated evidence suggesting that a polyclonal B cell activation is a primary etiologic defect of autoimmune diseases in both mice and humans. Based on this previous finding, the influence of various antiarthritic agents on lipopolysaccharide-induced B cell colony formation in mouse spleen cells was studied. When added to cell culture, aurothioglucose, chloroquine, and prostaglandin E1 had a suppressive effect on B cell colony formation at clinically relevant concentrations. A 50% suppression was obtained at 10-7 to 10-8 M for aurothioglucose, 10-7 M for chloroquine, and 10-7 to 10-8 M for prostaglandin E1, respectively. All of the immunosuppressive drugs and glucocorticoids examined decreased the number of colonies with a variety of intensity. Nonsteroidal antiinflammatory drugs have only a slight inhibitory effect at high concentrations. Both penicillamine and levamisole had no effect on B cell colony formation. This experimental system might be useful in searching for new and unique drugs and in evaluating the mode of action of drugs used against autoimmune diseases.

Original languageEnglish (US)
Pages (from-to)1-7
Number of pages7
JournalImmunopharmacology
Volume7
Issue number1
DOIs
StatePublished - 1984

Fingerprint

B-Lymphocytes
Aurothioglucose
Alprostadil
Chloroquine
Pharmaceutical Preparations
Autoimmune Diseases
Levamisole
Penicillamine
Immunosuppressive Agents
Glucocorticoids
Anti-Inflammatory Agents
Spleen
Cell Culture Techniques

Keywords

  • Antiarthritic drugs
  • Autoimmunity
  • B cell colony formation

ASJC Scopus subject areas

  • Pharmacology

Cite this

Inhibition by various antiarthritic agents of murine splenic B cell colony formation. / Ohsugi, Yoshiyuki; Gershwin, M. Eric.

In: Immunopharmacology, Vol. 7, No. 1, 1984, p. 1-7.

Research output: Contribution to journalArticle

@article{6cfbca679c4f41b7a16040ad30947dce,
title = "Inhibition by various antiarthritic agents of murine splenic B cell colony formation",
abstract = "There is accumulated evidence suggesting that a polyclonal B cell activation is a primary etiologic defect of autoimmune diseases in both mice and humans. Based on this previous finding, the influence of various antiarthritic agents on lipopolysaccharide-induced B cell colony formation in mouse spleen cells was studied. When added to cell culture, aurothioglucose, chloroquine, and prostaglandin E1 had a suppressive effect on B cell colony formation at clinically relevant concentrations. A 50{\%} suppression was obtained at 10-7 to 10-8 M for aurothioglucose, 10-7 M for chloroquine, and 10-7 to 10-8 M for prostaglandin E1, respectively. All of the immunosuppressive drugs and glucocorticoids examined decreased the number of colonies with a variety of intensity. Nonsteroidal antiinflammatory drugs have only a slight inhibitory effect at high concentrations. Both penicillamine and levamisole had no effect on B cell colony formation. This experimental system might be useful in searching for new and unique drugs and in evaluating the mode of action of drugs used against autoimmune diseases.",
keywords = "Antiarthritic drugs, Autoimmunity, B cell colony formation",
author = "Yoshiyuki Ohsugi and Gershwin, {M. Eric}",
year = "1984",
doi = "10.1016/0162-3109(84)90002-X",
language = "English (US)",
volume = "7",
pages = "1--7",
journal = "Immunopharmacology",
issn = "0162-3109",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Inhibition by various antiarthritic agents of murine splenic B cell colony formation

AU - Ohsugi, Yoshiyuki

AU - Gershwin, M. Eric

PY - 1984

Y1 - 1984

N2 - There is accumulated evidence suggesting that a polyclonal B cell activation is a primary etiologic defect of autoimmune diseases in both mice and humans. Based on this previous finding, the influence of various antiarthritic agents on lipopolysaccharide-induced B cell colony formation in mouse spleen cells was studied. When added to cell culture, aurothioglucose, chloroquine, and prostaglandin E1 had a suppressive effect on B cell colony formation at clinically relevant concentrations. A 50% suppression was obtained at 10-7 to 10-8 M for aurothioglucose, 10-7 M for chloroquine, and 10-7 to 10-8 M for prostaglandin E1, respectively. All of the immunosuppressive drugs and glucocorticoids examined decreased the number of colonies with a variety of intensity. Nonsteroidal antiinflammatory drugs have only a slight inhibitory effect at high concentrations. Both penicillamine and levamisole had no effect on B cell colony formation. This experimental system might be useful in searching for new and unique drugs and in evaluating the mode of action of drugs used against autoimmune diseases.

AB - There is accumulated evidence suggesting that a polyclonal B cell activation is a primary etiologic defect of autoimmune diseases in both mice and humans. Based on this previous finding, the influence of various antiarthritic agents on lipopolysaccharide-induced B cell colony formation in mouse spleen cells was studied. When added to cell culture, aurothioglucose, chloroquine, and prostaglandin E1 had a suppressive effect on B cell colony formation at clinically relevant concentrations. A 50% suppression was obtained at 10-7 to 10-8 M for aurothioglucose, 10-7 M for chloroquine, and 10-7 to 10-8 M for prostaglandin E1, respectively. All of the immunosuppressive drugs and glucocorticoids examined decreased the number of colonies with a variety of intensity. Nonsteroidal antiinflammatory drugs have only a slight inhibitory effect at high concentrations. Both penicillamine and levamisole had no effect on B cell colony formation. This experimental system might be useful in searching for new and unique drugs and in evaluating the mode of action of drugs used against autoimmune diseases.

KW - Antiarthritic drugs

KW - Autoimmunity

KW - B cell colony formation

UR - http://www.scopus.com/inward/record.url?scp=0021725158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021725158&partnerID=8YFLogxK

U2 - 10.1016/0162-3109(84)90002-X

DO - 10.1016/0162-3109(84)90002-X

M3 - Article

C2 - 6425240

AN - SCOPUS:0021725158

VL - 7

SP - 1

EP - 7

JO - Immunopharmacology

JF - Immunopharmacology

SN - 0162-3109

IS - 1

ER -